Tildrakizumab is an interleukin-23 antagonist used to treat moderate to severe plaque psoriasis. The DrugMonitor™ Anti-Tildrakizumab Antibody (VS-1224-YC1200) is an anti-drug antibody (ADA) against Tildrakizumab. This drug-based antibody is raised in mice immunized with the Tildrakizumab. The anti-Tildrakizumab antibody may be used in ELISA, pharmacokinetics (PK), and pharmacodynamics (PD) analyses, or serves as a reference standard in ADA assays. It also is an excellent tool for therapeutic drug monitoring, allowing to evaluate the drug efficacy and determine the drug concentration of the Tildrakizumab in samples.
Download resources about recombinant antibody development and antibody engineering to boost your research.
Anti-Human IL23 Recombinant Antibody (Tildrakizumab)Recombinant humanized (from mouse) antibody expressed in CHO binding to human IL23. Tildrakizumab is a monoclonal antibody designed for the treatment of immunologically mediated inflammatory disorders.
Afuco™ Anti-IL23A ADCC Recombinant Antibody, ADCC Enhanced (AFC-TAB-875)This product is an ADCC enhanced antibody produced by our Afuco™ platform. Recombinant humanized (from mouse) antibody expressed in CHO binding to human IL23. It is a monoclonal antibody designed for the treatment of immunologically mediated inflammatory disorders.
There are currently no Customer reviews or questions for VS-1224-YC1200. Click the button above to contact us or submit your feedback about this product.
For Research Use Only. Not For Clinical Use.
For research use only. Not intended for any clinical use. No products from Creative Biolabs may be resold, modified for resale or used to manufacture commercial products without prior written approval from Creative Biolabs.
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.